Log in to save to my catalogue

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_729fb5b9e7544bd191b10488b78de1e8

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

About this item

Full title

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-10, Vol.11 (1), p.19582-19582, Article 19582

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Levodopa is the standard long-term dopamine replacement therapy to treat Parkinson’s disease (PD) symptoms. With time, levodopa may induce debilitating dyskinesias (LID), the treatment of which represents a large clinically unmet need. However, time-to-LID onset varies between patients, reflecting a possible genetic component. We performed an hypot...

Alternative Titles

Full title

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_729fb5b9e7544bd191b10488b78de1e8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_729fb5b9e7544bd191b10488b78de1e8

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-99393-8

How to access this item